A single genetic variant in the ABCC11 gene quietly shapes several visible and invisible traits, from the consistency of your earwax to how much you sweat and whether you produce noticeable body odor. The variant, a one-letter swap at position 538 of the gene (G to A), reaches its highest frequency in East Asian populations, where the vast majority of people carry two copies of the A version. That frequency pattern has made ABCC11 one of the clearest examples of a gene shaped by geographically restricted natural selection, and its downstream effects ripple into areas most people would never connect to earwax.
What the ABCC11 Gene Actually Does
ABCC11 codes for a transporter protein that sits in the membrane of certain secretory cells, particularly in the ear canal, armpit sweat glands, and breast tissue. Its job is to pump molecules out of cells, including lipids, signaling molecules, and metabolic byproducts. The critical variant is a change from G to A at position 538 of the gene’s coding sequence. People who inherit two copies of the A version (the AA genotype) produce a transporter with much lower pumping activity, which reduces the volume and composition of secretions from those glands. People with one or two copies of the G version (GA or GG) produce a fully functional transporter that moves those substances out more efficiently.
1PubMed. A SNP in the ABCC11 gene is the determinant of human earwax typeIn practical terms, the G version is dominant: you only need one copy to get the “wet” phenotype across earwax, body odor, and other traits. The A version is recessive, so both copies must be A for the “dry” set of traits to appear. This all-or-nothing pattern is what makes the gene so interesting from a population genetics standpoint, because the A allele didn’t just drift to high frequency in East Asia. It was pushed there by natural selection.
Dry Versus Wet Earwax
The most immediately noticeable trait governed by ABCC11 is earwax type. Wet earwax is sticky, yellowish-brown, and relatively abundant. Dry earwax is flaky, grayish, and produced in smaller quantities. The difference isn’t cosmetic fluff; it reflects a genuine change in glandular secretion. The ceruminous glands in the ear canal are a type of modified apocrine gland, and when the ABCC11 transporter works at full capacity (the G allele), it pumps out more lipids and other compounds, producing the wet type.
2PubMed. Earwax, osmidrosis, and breast cancer: why does one SNP (538G>A) in the human ABC transporter ABCC11 gene determine earwax type?Chemical analysis confirms that the two earwax types differ in both the quantity and makeup of their lipids. Both contain squalene, steryl esters, wax esters, triglycerides, free fatty acids, and cholesterol, but wet earwax also contains additional lipid fractions not found in the dry type. The composition shift means wet earwax is literally oilier and stickier.
3Yonsei Medical Journal. Lipid Composition of Ear Wax in HircismusIn most of Africa, nearly everyone has wet earwax. In Europe, the split leans toward wet but with a meaningful minority of dry-type carriers. In East Asia, dry earwax is the overwhelming norm. The geographic pattern is so stark that earwax type was historically used in forensic anthropology as a rough marker of ancestry before modern DNA profiling replaced it.
Body Odor and the Apocrine Sweat Glands
The same transporter that shapes earwax also operates in the apocrine sweat glands concentrated in the armpits. These glands secrete a milky fluid that is initially odorless. The smell comes later, when skin bacteria break down certain molecules in that fluid, especially sulfur-containing amino acid conjugates. ABCC11 is responsible for pumping those odor precursor molecules out of the gland cells and into the secretory fluid in the first place.
4Journal of Investigative Dermatology. A Functional ABCC11 Allele Is Essential in the Biochemical Formation of Human Axillary OdorIf you carry two copies of the A allele, your apocrine glands simply don’t export those precursors effectively. The bacteria on your skin have far less to work with, so significantly less odor is produced. Research has mapped out the biochemical chain: inside the gland cell, apocrine metabolism produces an odorless glutathione conjugate, which the ABCC11 transporter loads into secretory vesicles. After further processing and release onto the skin surface, bacteria convert it into the volatile thiol compounds that produce underarm smell.
5PubMed Central. Interplay of human ABCC11 transporter gene variants with axillary skin microbiome functional genomicsThe clinical version of strong body odor, called axillary osmidrosis, is formally linked to the ABCC11 genotype. In a Japanese study, about 99% of people diagnosed with osmidrosis carried at least one G allele, compared to roughly 35% in the general Japanese population.
6PubMed Central. A strong association of axillary osmidrosis with the wet earwax type determined by genotyping of the ABCC11 geneA larger study in the Chinese Han population confirmed the association, finding that the G allele was overwhelmingly linked to osmidrosis risk. People carrying the G allele were also more likely to have wet earwax, a family history of the condition, and an earlier age when symptoms appeared.
7PubMed Central. A missense variant of the ABCC11 gene is associated with Axillary Osmidrosis susceptibility and clinical phenotypes in the Chinese Han PopulationThis has practical clinical consequences. In East Asian countries where most people carry the dry-type genotype, the relatively small number who produce strong body odor can experience real social distress. Genotyping the ABCC11 variant has been proposed as a diagnostic tool for osmidrosis, helping clinicians confirm the diagnosis before recommending surgical or procedural treatments.
8PubMed Central. Diagnosis of Human Axillary Osmidrosis by Genotyping of the Human ABCC11 Gene: Clinical Practice and Basic Scientific EvidenceWhy the A Allele Swept Through East Asia
The A allele didn’t reach near-fixation in East Asian populations by chance. Genome-wide scans for signatures of positive selection flagged the region around ABCC11 as having undergone a selective sweep specific to East Asians. By analyzing genetic markers flanking the variant and running coalescent simulations, researchers estimated that the A allele arose roughly 2,000 generations ago, with a wide confidence interval stretching from about 1,000 to 4,000 generations. The estimated selection coefficient was around 0.01, which in evolutionary terms means the allele provided a small but consistent survival or reproductive advantage each generation.
9PubMed. The impact of natural selection on an ABCC11 SNP determining earwax typeOne of the more striking findings is that absolute latitude correlates with the frequency of the A allele across Asian, Native American, and European populations. The farther from the equator, the more common the dry-type allele tends to be. This pattern held even after accounting for different migration histories in those continental groups. African populations were excluded from the analysis because the A allele is essentially absent there.
10Molecular Biology and Evolution. The Impact of Natural Selection on an ABCC11 SNP Determining Earwax TypeThe latitude correlation points toward cold-climate adaptation, though the exact mechanism remains debated. One hypothesis is that reduced apocrine secretion was directly advantageous in cold, dry environments, perhaps by limiting skin moisture loss or reducing frostbite risk. Another possibility is that the A allele hitchhiked alongside some other beneficial variant in the same genomic region. What’s clear is that the selective pressure was real and geographically specific. The allele’s near-absence in Africa and moderate frequency in Europe, compared to its dominance in East Asia, is one of the sharpest cases of population-specific selection at a single gene in the human genome.
Deodorant Use and Consumer Behavior
If your body doesn’t produce much underarm odor, you might not bother with deodorant. That intuition turns out to be genetically measurable. A study of roughly 17,000 individuals in a British cohort found strong evidence that people homozygous for the A allele (AA genotype) were almost five times more likely to report never using deodorant or using it only occasionally, compared to carriers of the G allele.
11PubMed Central. Dependence of deodorant usage on ABCC11 genotype: scope for personalized genetics in personal hygieneSince the AA genotype is rare in people of European descent, this finding affected only a small fraction of the British study population. But in East Asian countries, where AA is the majority genotype, the commercial and cultural implications are substantial. The deodorant market in Japan and South Korea is a fraction of the size you’d expect from their populations, and the products that do sell tend to target the minority who carry the wet-type allele. The gene essentially segments an entire consumer category along population lines, a pattern that personal care companies have long noticed empirically even if they didn’t frame it in genetic terms.
Colostrum Secretion and Breast Tissue
ABCC11 is also expressed in mammary gland tissue, and its effects there follow the same pattern seen in the ear canal and armpits. The breast’s apocrine glands rely on the transporter to secrete certain compounds, and the variant influences how actively those glands function during early lactation.
A study of 225 Japanese women found that those with the dry-type genotype (AA) were significantly more likely to produce no measurable colostrum, and among those who did produce it, the volume was smaller than in women with at least one G allele.
12Human Genetics. A strong association between human earwax-type and apocrine colostrum secretion from the mammary glandThe wild-type G allele has also been linked to a higher likelihood of mastopathy, a benign breast condition characterized by cystic or fibrous changes in breast tissue, consistent with more active secretory gland function.
13PubMed Central. Pharmacogenetics of human ABC transporter ABCC11: new insights into apocrine gland growth and metabolite secretionThese findings don’t mean that women with dry-type earwax can’t breastfeed; mature milk production depends on a different set of glandular processes and hormones. Colostrum is the thick, nutrient-rich fluid produced in the first days after birth, and the ABCC11 connection appears limited to that early secretory phase. Still, it’s a useful reminder that a gene known mainly for earwax reaches into tissue types most people wouldn’t suspect.
Breast Cancer Risk Remains Unresolved
Because ABCC11 is expressed in breast tissue and can pump out estrogen metabolites, researchers have asked whether the variant influences breast cancer risk. A Japanese study found that women carrying the G allele (the wet-earwax type) had a higher frequency of breast cancer compared to healthy controls, with an odds ratio of about 1.63.
14PubMed. Association between breast cancer risk and the wild-type allele of human ABC transporter ABCC11However, a follow-up study in a German population of over 2,000 women found no such association. The researchers specifically set out to confirm or refute the Japanese finding and concluded that the ABCC11 variant does not contribute to breast cancer risk in women of European descent.
15PubMed. The earwax-associated SNP c.538G>A (G180R) in ABCC11 is not associated with breast cancer risk in EuropeansThe discrepancy might reflect genuine population-specific effects. In Japanese populations, the G allele is in the minority, so people who carry it may also carry different genetic backgrounds and environmental exposures compared to European populations where the G allele is dominant. It’s also possible that the original Japanese finding was a statistical artifact of the allele frequency distribution. The evidence is currently too thin and contradictory to treat ABCC11 status as a meaningful breast cancer marker in any population.
Drug Resistance in Cancer Treatment
Beyond its glandular roles, ABCC11 has a darker side in oncology. The transporter can pump chemotherapy drugs out of cancer cells, reducing the drugs’ effectiveness. The most clinically relevant case involves 5-fluorouracil (5-FU), a widely used cancer treatment. When cancer cells overexpress the ABCC11 gene, they gain the ability to eject the active metabolite of 5-FU, reducing its accumulation inside the cell. In one study using a resistant lung cancer cell line, ABCC11 overexpression increased 5-FU resistance by roughly 25-fold.
16PubMed. MRP8/ABCC11 directly confers resistance to 5-fluorouracilThe transporter’s substrate range is broad. Laboratory experiments have shown that cells with high ABCC11 expression resist not only 5-FU but also other nucleotide-based drugs, including agents used against HIV and hepatitis B. The resistance operates through the same mechanism: the transporter recognizes the drug’s active metabolite as cargo and pumps it out before it can do its job.
17Journal of Biological Chemistry. MRP8, ATP-binding Cassette C11 (ABCC11), Is a Cyclic Nucleotide Efflux Pump and a Resistance Factor for Fluoropyrimidines 2′,3′-Dideoxycytidine and 9′-(2′-Phosphonylmethoxyethyl)adenineThis raises a pharmacogenomic question: does a patient’s ABCC11 genotype predict how well they respond to 5-FU-based chemotherapy? The theoretical logic is compelling. People with the AA genotype produce a transporter with greatly reduced function, so their cancer cells might be less able to expel the drug. But this remains largely theoretical for now. Most of the resistance data come from lab cell lines rather than clinical trials, and tumors can overexpress ABCC11 regardless of what the patient’s inherited genotype is. The gene’s role in drug efflux is well-established in the lab, but translating that into bedside predictions is still a work in progress.
18PubMed Central. Pharmacogenomics of human ABC transporter ABCC11 (MRP8): potential risk of breast cancer and chemotherapy failureHow the Gene Reshapes Your Skin Bacteria
The ABCC11 variant doesn’t just change what your glands secrete; it changes which bacteria thrive on your skin. A study of Japanese adults found that carrying the wet-earwax allele (G) at rs17822931 decreased the relative abundance of Corynebacterium in the armpit and increased the relative abundance of Staphylococcus. The overall microbial community structure differed significantly between carriers and non-carriers, as measured by diversity metrics.
19PubMed. Association of HLA-DPB1, NLRP10, OVOL1, and ABCC11 with the axillary microbiome in a Japanese populationThis is relevant because Corynebacterium species are the primary bacteria responsible for converting odorless sweat precursors into the volatile compounds that produce underarm smell. At first glance, you might expect more Corynebacterium in people with the wet type, since they produce more odor. But the relationship between precursor supply and bacterial community composition is more complex than a simple “more food, more bacteria” story. Staphylococcus species also metabolize sweat compounds, and the balance between the two groups may shift depending on the chemical environment the ABCC11 variant creates.
The microbiome angle adds another layer to the body odor story. It’s not just that the G allele delivers more odor precursors to the skin surface. The allele also reshapes the bacterial ecosystem that processes those precursors, potentially amplifying or modifying the final odor profile. For people with the AA genotype, the combination of fewer precursors and a different bacterial community means the entire odor-production chain is suppressed at multiple points, which helps explain why the phenotypic difference between dry and wet types is so pronounced in everyday life.
A Single Gene With an Unusually Wide Reach
Most genes that differ sharply between human populations affect a narrow trait. Skin pigmentation genes affect skin color. Lactase persistence affects milk digestion. ABCC11 is unusual because one variant simultaneously influences earwax, body odor, armpit bacteria, colostrum production, and potentially cancer drug resistance. The reason is the transporter’s broad substrate range: it pumps lipids, cyclic nucleotides, amino acid conjugates, and drug metabolites with roughly equal indifference. Any cell type that expresses ABCC11 and relies on it for secretion gets affected by the variant.
That breadth is also why researchers keep finding new ABCC11-associated phenotypes decades after the gene was first linked to earwax in 2006. Each tissue where the transporter is active represents another potential discovery. The gene has become something of a model system for understanding how a single common variant can produce a package of traits that track together across populations, all tracing back to how vigorously one pump moves molecules across a cell membrane.